News

Under the proposed terms, Cell Therapeutics would issue the company’s shareholders 29,000,000 shares of Cell Therapeutics’ common stock, representing 19.9% of Cell Therapeutics’ outstanding shares of common stock.

Health Canada has issued a Notice of Compliance with conditions which confers marketing approval to the drug in Canada, while requiring the company to continue with a confirmatory

The investigational new drug application allows the commencement of a phase III multiple sclerosis (MS) trial in the US and has been granted on the basis of satisfying

“Our goal is to cure the cancer as effectively as we can while using as few treatments as possible,” said Ramesh Rengan, assistant professor at University of Pennsylvania

The study enrolled healthy male volunteers to compare 48mg of cannabinor delivered intravenously versus placebo on capsaicin induced pain. Capsaicin is the active ingredient in chili peppers. The

The primary study end-point was overall survival and the secondary endpoints were relapse free survival and safety. Both primary and secondary efficacy objectives of the study have been

A total of 184 post-menopausal women out of 217 women randomized to the phase II study, started in October 2006, have completed their 12-week, off-study medication visit. To

The imaging compounds will be developed for diseases such as Alzheimer’s disease, Parkinson’s disease and other disorders also associated with neuroinflammation such as multiple sclerosis. Taisho Pharmaceutical, Nihon

The record profits can also be attributed to the fact that demand for its liquid crystals has increased, said the German drug maker. Merck reported strong performances in